JP Sevilla is a Senior Economist at Data for Decisions, LLC, an economics consultancy, and a Research Associate at the Harvard Chan School of Public Health. He currently researches the theory and empirics of the economic evaluation of vaccines and other health technologies. How much should society (or the public sector) be willing to pay for vaccines? How should we value its lifesaving benefits in monetary terms? Should only the health benefits of vaccines matter, or do their broader socio-economic benefits matter too? If the latter, how do we assess the relative value of such heterogeneous goods as health, economic growth, poverty alleviation and equity, risk reduction, peace of mind, and pandemic risk reduction? How balance the pharmaceutical industry’s needs for sufficiently high prices to sustain incentives to innovate with the developing world’s needs for sufficiently low prices to ensure accessibility? And how should policymakers in both rich and poor countries with highly strained budgets and a wide range of urgent needs in every aspect of their people’s lives think about the appropriate role of vaccines in their countries’ over-all socio-economic development?
JP Sevilla has previously been on the faculty of the Harvard Chan School of Public Health, a Research Fellow at Harvard Law School, and a consultant for clients such as the World Health Organization, Gates Foundation, and the Asian Development Bank. His other research interests are in ethical issues in social choice and priority-setting, global health, and law and economics. He has a Ph.D. in Economics from Harvard University and a JD from George Mason University.